How much does Roche Diabetes Care Limited make?

Roche Diabetes Care Limited reported revenue of £0 and a loss of £194k in the year to 31 Dec 2025, according to its accounts filed at Companies House.

Is Roche Diabetes Care Limited profitable?

No — Roche Diabetes Care Limited reported a loss of £194k in the year to 31 Dec 2025.

Company No. 09055599 · Incorporated 23 May 2014

Roche Diabetes Care Limited

Registered name: ROCHE DIABETES CARE LIMITED

Part of Roche Holding Ag group

Roche Diabetes Care Limited made £0 revenue and a £194k loss in the year to 31 Dec 2025.

Roche Diabetes Care Limited’s revenue fell 100% to £0 in the year to 31 Dec 2025, with a loss of £194k. The company is classified under “other business support service activities” and is based in Burgess Hill; we hold 3 years of its filed accounts.

Full P&L filedSIC 82990Other business support service activities n.e.c.

Status: Active
Location: Burgess Hill
Age: 12 yrs · since 2014
Type: Private Limited Company

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

£0

Growth ▼100%

Profit

−£194k

Growth ▼115.2%

Profit margin

—

Employees

—

Change —

Profit / employee

—

Profitable streak

0yrs

Consecutive profitable years in our data

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£26.2m	£21.4m	£0
Cost of sales	−£17.2m	−£15.5m	£0
Gross profit	£9m	£5.9m	£0
Operating profit	£1.2m	£1.3m	£0
Profit before tax	£1.8m	£1.6m	£0
Profit after tax	£1.3m	£1.3m	−£194k
Profit (best available)	£1.3m	£1.3m	−£194k
Employees (average)	70	34	—
Ratios
Profit margin	4.8%	6%	—
Gross margin	34.2%	27.5%	—
Revenue per employee	£374k	£628k	—
Profit per employee	£18.1k	£37.6k	—
Growth (year on year)
Revenue growth	—	▼18.5%	▼100%
Profit growth	—	▲0.8%	▼115.2%
Headcount growth	—	▼51.4%	—
Balance sheet — indirect signals, not revenue
Net assets	—	—	—
Source	Accounts · bulk data Sep 2025	Accounts · bulk data Sep 2025	Accounts · bulk data Oct 2026

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: —; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now —
Cash at bank: —; Now —
Headcount: —; Now —
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Ownership chain

Roche Holding Ag (registered outside the UK register)ultimate parent75–100%
Roche Holding (UK) Limited75–100%
Roche Diabetes Care Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (3)

Intermune Holdings LimitedFigures not disclosed
Roche Diagnostics LimitedFigures not disclosed
Roche Products LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Sources

Companies House profile Filing history & original accounts

Latest figures from accounts for the year to 31 Dec 2025 (profit −£194k), from the Companies House accounts bulk data published Oct 2026. Spotted an error? Request a correction.

Updated from Companies House on 23 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.